Immune Resolution Dilemma: Host Antimicrobial Factor S100A8/A9 Modulates Inflammatory Collateral Tissue Damage During Disseminated Fungal PeritonitisVisa övriga samt affilieringar
2021 (Engelska)Ingår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 12, artikel-id 553911
Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Intra-abdominal infection (peritonitis) is a leading cause of severe disease in surgical intensive care units, as over 70% of patients diagnosed with peritonitis develop septic shock. A critical role of the immune system is to return to homeostasis after combating infection. S100A8/A9 (calprotectin) is an antimicrobial and pro-inflammatory protein complex used as a biomarker for diagnosis of numerous inflammatory disorders. Here we describe the role of S100A8/A9 in inflammatory collateral tissue damage (ICTD). Using a mouse model of disseminated intra-abdominal candidiasis (IAC) in wild-type and S100A8/A9-deficient mice in the presence or absence of S100A9 inhibitor paquinimod, the role of S100A8/A9 during ICTD and fungal clearance were investigated. S100A8/A9-deficient mice developed less ICTD than wild-type mice. Restoration of S100A8/A9 in knockout mice by injection of recombinant protein resulted in increased ICTD and fungal clearance comparable to wild-type levels. Treatment with paquinimod abolished ICTD and S100A9-deficient mice showed increased survival compared to wild-type littermates. The data indicates that S100A8/A9 controls ICTD levels and antimicrobial activity during IAC and that targeting of S100A8/A9 could serve as promising adjunct therapy against this challenging disease.
Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2021. Vol. 12, artikel-id 553911
Nyckelord [en]
Candida albicans, host-pathogen interactions, host-targeted agents, inflammation, peritonitis, S100A8/A9 complex, sepsis
Nationell ämneskategori
Immunologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:umu:diva-181798DOI: 10.3389/fimmu.2021.553911ISI: 000627778800001Scopus ID: 2-s2.0-85102439343OAI: oai:DiVA.org:umu-181798DiVA, id: diva2:1541456
Forskningsfinansiär
Kempestiftelserna, SMK-1453Vetenskapsrådet, VR-M 2017-01681Vetenskapsrådet, 2014-022812021-04-012021-04-012024-08-05Bibliografiskt granskad